AI assistant
HAEMONETICS CORP — Director's Dealing 2024
May 17, 2024
31565_dirs_2024-05-17_50c30fe7-d412-40fc-8e48-ad049faad6b9.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: HAEMONETICS CORP (HAE)
CIK: 0000313143
Period of Report: 2024-05-15
Reporting Person: Strong Stewart W (President, Global Hospital)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2024-05-15 | Common Stock | F | 241 | $96.49 | Disposed | 15860 | Direct |
| 2024-05-16 | Common Stock | F | 252 | $94.80 | Disposed | 15608 | Direct |
| 2024-05-16 | Common Stock | M | 2410 | $57.60 | Acquired | 18018 | Direct |
| 2024-05-16 | Common Stock | F | 1677 | $96.14 | Disposed | 16341 | Direct |
| 2024-05-16 | Common Stock | S | 733 | $96.04 | Disposed | 15608 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2024-05-16 | Non-qualified Stock Option (Right to Buy) | $57.60 | M | 2410 | Disposed | 2029-05-16 | Common Stock (2410) | Direct |
Footnotes
F1: Represents shares withheld for tax obligations in connection with the vesting of certain restricted stock units ("RSUs") previously reported in Table I.
F2: This number includes unvested restricted stock units previously reported.
F3: Transaction pursuant to an existing 10b5-1 trading plan dated June 12, 2023 (fully executed as of June 12, 2023).
F4: Represents shares withheld for tax obligations and for payment of the exercise price on exercised stock options reported in Table I.
F5: Option vests in annual increments of 25% beginning on the first anniversary of the date of grant.